Cai Li, Wang Gaoming, Zhang Peijun, Hu Xinyi, Zhang Hao, Wang Fan, Tong Yeqing
Wuhan Center for Disease Control and Prevention, Wuhan, China.
School of Health Sciences, Wuhan University, Wuhan, China.
Front Nutr. 2022 May 17;9:873890. doi: 10.3389/fnut.2022.873890. eCollection 2022.
The progressions of a number of lung diseases, including acute lung injury, cystic fibrosis, asthma, chronic obstructive pulmonary disease, pneumonia and tuberculosis (TB) are found to be highly associated with inflammatory responses. As a signaling nutrient, Vitamin D modulates the activities of dendritic cells, monocytes/macrophages, T and B cells, and tissue epithelial cells in the body to induce inflammatory responses and boost immune functions. Given the high prevalence of vitamin D deficiency among pulmonary insufficiency and inflammation-related cases, researchers indicated vitamin D supplementation could have a potential role in the prevention and treatment of lung disease, especially tuberculosis. In this paper, we reviewed published studies on the role of vitamin D in the prevention and treatment of tuberculosis. The paper identified vitamin D's potential as an adjunctive therapy and demonstrated its safety so as to provide an impetus for further studies and clinical applications.
人们发现,包括急性肺损伤、囊性纤维化、哮喘、慢性阻塞性肺疾病、肺炎和肺结核(TB)在内的多种肺部疾病的进展都与炎症反应高度相关。作为一种信号营养素,维生素D可调节体内树突状细胞、单核细胞/巨噬细胞、T细胞和B细胞以及组织上皮细胞的活性,以诱导炎症反应并增强免疫功能。鉴于维生素D缺乏在肺功能不全和炎症相关病例中普遍存在,研究人员指出补充维生素D可能在肺部疾病尤其是肺结核的预防和治疗中发挥潜在作用。在本文中,我们回顾了已发表的关于维生素D在肺结核预防和治疗中作用的研究。该论文确定了维生素D作为辅助治疗的潜力,并证明了其安全性,从而为进一步的研究和临床应用提供了动力。